Profile data is unavailable for this security.
About the company
Chimin Health Management Co Ltd is a China-based company primarily engaged in the manufacturing of medical consumables. The Company's core businesses include three main segments: medical services; the research, development, production, and sales of medical devices; and the research, development, production, and sales of infusion solutions. The Company's medical device products primarily include injection and puncture instruments, prefilled catheter flushers, and in vitro diagnostic products. The Company's infusion solutions are categorized by packaging, including non-PVC soft bags, plastic bottles, and stand-up soft bags. They are also categorized by use, including basic infusion solutions, electrolyte solutions, flushing agents, and therapeutic infusion solutions.
- Revenue in CNY (TTM)637.78m
- Net income in CNY-165.28m
- Incorporated1996
- Employees1.99k
- LocationChimin Health Management Co LtdNo. 888, Beiyuan Road, Huangyan DistrictTAIZHOU 318020ChinaCHN
- Phone+86 57 684066800
- Fax+86 57 684066800
- Websitehttps://www.chimin.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jianerkang Medical Co Ltd | 988.21m | 103.17m | 4.35bn | 1.64k | 17.49 | 2.98 | -- | 4.40 | 1.59 | 1.59 | 8.03 | 9.35 | 0.6961 | 4.54 | 4.50 | 603,301.80 | 7.27 | -- | 8.08 | -- | 23.15 | -- | 10.44 | -- | 7.07 | -- | 0.0146 | -- | 1.18 | -- | -2.69 | -- | -- | -- |
| Well Lead Medical Co Ltd | 1.64bn | 244.31m | 4.38bn | 2.76k | 18.11 | 2.26 | -- | 2.67 | 0.8288 | 0.8288 | 5.57 | 6.63 | 0.5811 | 4.75 | 6.81 | 593,586.30 | 9.07 | 8.23 | 11.07 | 10.15 | 42.85 | 43.50 | 15.61 | 13.60 | 1.39 | 82.37 | 0.2436 | 57.82 | 8.76 | 8.72 | 13.98 | 12.61 | 22.91 | 26.58 |
| Getein Biotech Inc | 1.04bn | 181.90m | 4.41bn | 1.95k | 24.23 | 1.64 | -- | 4.23 | 0.3587 | 0.3587 | 2.06 | 5.31 | 0.2683 | 1.68 | 2.68 | 535,523.10 | 4.41 | 10.90 | 6.31 | 15.53 | 67.54 | 64.96 | 16.43 | 25.58 | 2.14 | -- | 0.1839 | 31.15 | -14.93 | 3.77 | -20.06 | -8.02 | 4.62 | -2.48 |
| Nanjing Medlander Medical Tech Co Ltd | 437.82m | 101.51m | 4.51bn | 582.00 | 43.46 | 3.30 | -- | 10.30 | 1.04 | 1.04 | 4.47 | 13.68 | 0.2865 | 2.18 | 15.40 | 752,267.60 | 6.81 | 11.96 | 7.54 | 13.89 | 69.16 | 71.98 | 23.76 | 31.41 | 8.22 | -- | 0.0268 | 48.42 | 24.57 | 10.68 | 13.10 | -0.8601 | 23.21 | -- |
| CareRay Digital Medical Technology CoLtd | 328.62m | 5.41m | 4.59bn | 282.00 | 798.86 | 5.34 | -- | 13.95 | 0.0651 | 0.0651 | 3.79 | 9.74 | 0.3392 | 1.69 | 3.66 | 1,165,314.00 | 0.5362 | 4.81 | 0.5972 | 5.27 | 36.13 | 40.00 | 1.58 | 12.87 | 3.57 | 1.77 | 0.0497 | 34.94 | 8.90 | 4.91 | 14.54 | -18.19 | 85.59 | -- |
| Thalys Medical Technology Group Corp | 1.25bn | -240.46m | 4.59bn | 1.25k | -- | 4.20 | -- | 3.68 | -1.35 | -1.35 | 6.55 | 5.19 | 0.4777 | 3.80 | 1.12 | 1,001,425.00 | -9.15 | -2.70 | -16.94 | -4.93 | 18.26 | 20.43 | -19.16 | -4.59 | 1.16 | -2.08 | 0.357 | -- | -9.74 | -0.2204 | -31.95 | -- | -24.80 | -- |
| Chimin Health Management Co Ltd | 637.78m | -165.28m | 4.59bn | 1.99k | -- | 3.27 | -- | 7.20 | -0.3276 | -0.3276 | 1.24 | 2.67 | 0.2591 | 3.15 | 3.72 | 319,848.50 | -6.70 | 0.4271 | -9.09 | 0.6335 | 27.94 | 42.63 | -25.86 | 1.16 | 0.8238 | -8.24 | 0.3308 | 65.53 | -13.28 | 0.1151 | 8.81 | -- | -1.88 | -- |
| Innovita Biological Technology Co Ltd | 430.96m | 133.44m | 4.79bn | 547.00 | 35.74 | 2.36 | -- | 11.11 | 0.9778 | 0.9778 | 3.15 | 14.84 | 0.1992 | 2.28 | 12.73 | 787,869.50 | 6.17 | 18.66 | 6.52 | 20.97 | 76.43 | 78.34 | 30.96 | 43.42 | 16.16 | -- | 0.0025 | 12.05 | 29.99 | 35.11 | 41.92 | 63.25 | 28.63 | -- |
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.92bn | 744.00 | 18.01 | 1.98 | -- | 7.36 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Chimin Health Management Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 996.66k | 0.19% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 428.40k | 0.08% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 253.20k | 0.05% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 93.28k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 73.36k | 0.01% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 55.62k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 41.40k | 0.01% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 39.72k | 0.01% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 38.66k | 0.01% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 29.90k | 0.01% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
